X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (21) 21
humans (14) 14
mutation (12) 12
article (10) 10
cancer (8) 8
female (8) 8
leukemia (8) 8
abridged index medicus (7) 7
hematology (7) 7
leukemia, myeloid, acute - genetics (7) 7
male (7) 7
adult (6) 6
hemic and lymphatic diseases (6) 6
middle aged (6) 6
research (6) 6
acute myeloid leukemia (5) 5
acute myeloid-leukemia (5) 5
animals (5) 5
chemotherapy (5) 5
leukemia, myeloid, acute - drug therapy (5) 5
medical research (5) 5
medicine (5) 5
medicine, general & internal (5) 5
oncology (5) 5
usage (5) 5
bone marrow (4) 4
cell biology (4) 4
expression (4) 4
gene expression (4) 4
mice (4) 4
mutations (4) 4
myeloid leukemia (4) 4
oncogene proteins, fusion - genetics (4) 4
risk factors (4) 4
acute promyelocytic leukemia (3) 3
aged (3) 3
azacitidine - administration & dosage (3) 3
azacitidine - analogs & derivatives (3) 3
care and treatment (3) 3
clonal hematopoiesis (3) 3
disease progression (3) 3
dna methylation (3) 3
flow cytometry (3) 3
gene mutations (3) 3
genes (3) 3
genetic aspects (3) 3
genomes (3) 3
genomics (3) 3
hematopoietic stem cells (3) 3
hemopoiesis (3) 3
leukemia, myeloid, acute - pathology (3) 3
myelodysplastic syndrome (3) 3
myelodysplastic syndromes - drug therapy (3) 3
myelodysplastic syndromes - genetics (3) 3
neoplasms (3) 3
patients (3) 3
recurrence (3) 3
research article (3) 3
somatic mutations (3) 3
transcription (3) 3
5-aza-2'-deoxycytidine (2) 2
acute lymphoblastic-leukemia (2) 2
aged, 80 and over (2) 2
amino acid sequence (2) 2
aml (2) 2
analysis (2) 2
antimetabolites, antineoplastic - administration & dosage (2) 2
antimetabolites, antineoplastic - adverse effects (2) 2
azacitidine - adverse effects (2) 2
base sequence (2) 2
biochemistry & molecular biology (2) 2
biology (2) 2
cancer therapies (2) 2
cathepsin g - genetics (2) 2
cells (2) 2
chromatin (2) 2
classification (2) 2
clonal evolution (2) 2
cpg islands (2) 2
disease-free survival (2) 2
dna mutational analysis (2) 2
dna sequencing (2) 2
evolution (2) 2
genome, human (2) 2
hematopoietic stem cells - metabolism (2) 2
immunology (2) 2
leukemia, myeloid, acute - mortality (2) 2
leukemia, promyelocytic, acute - genetics (2) 2
medical colleges (2) 2
medicine, experimental (2) 2
methylation (2) 2
mice, 129 strain (2) 2
minimal residual disease (2) 2
molecular sequence data (2) 2
myelodysplastic syndromes (2) 2
myelodysplastic syndromes - mortality (2) 2
nucleotide sequencing (2) 2
older patients (2) 2
patterns (2) 2
phenotypes (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell, ISSN 0092-8674, 07/2012, Volume 150, Issue 2, pp. 264 - 278
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 21, pp. 2023 - 2036
Journal Article
Cancer Medicine, ISSN 2045-7634, 12/2017, Volume 6, Issue 12, pp. 2814 - 2821
Decitabine has been explored as a reduced‐intensity therapy for older or unfit patients with acute myeloid leukemia (AML). To better understand the risk of... 
AML | neutropenic fever | decitabine | VANCOMYCIN-RESISTANT | 1ST-LINE TREATMENT | MULTICENTER | 5-AZA-2'-DEOXYCYTIDINE | ADULTS | PHASE-II | NEUTROPENIC PATIENTS | CANCER | OLDER PATIENTS | ONCOLOGY | BACTEREMIA | Azacitidine - adverse effects | Gram-Negative Bacterial Infections - chemically induced | Humans | Middle Aged | Gram-Positive Bacterial Infections - mortality | Mycoses - microbiology | Decitabine | Fever - mortality | Male | Opportunistic Infections - mortality | Virus Diseases - virology | Fever - chemically induced | Gram-Positive Bacterial Infections - chemically induced | Opportunistic Infections - chemically induced | Antimetabolites, Antineoplastic - administration & dosage | Incidence | Gram-Negative Bacterial Infections - microbiology | Time Factors | Gram-Positive Bacterial Infections - microbiology | Missouri | Neutropenia - mortality | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Retrospective Studies | Neutropenia - chemically induced | Myelodysplastic Syndromes - drug therapy | Azacitidine - administration & dosage | Virus Diseases - chemically induced | Drug Administration Schedule | Risk Assessment | Risk Factors | Azacitidine - analogs & derivatives | Treatment Outcome | Opportunistic Infections - diagnosis | Opportunistic Infections - microbiology | Myelodysplastic Syndromes - diagnosis | Leukemia, Myeloid, Acute - diagnosis | Antimetabolites, Antineoplastic - adverse effects | Aged | Virus Diseases - mortality | Mycoses - mortality | Gram-Negative Bacterial Infections - mortality | Mycoses - chemically induced | Antimitotic agents | Complications and side effects | Medical research | Medical colleges | Mortality | Medicine, Experimental | Antineoplastic agents | Myeloid leukemia | Leukemia | Gram-positive bacteria | Bacteria | Infections | Acute myeloid leukemia | Patients | Myelodysplastic syndrome | 5-aza-2'-deoxycytidine | Index Medicus
Journal Article
by Ley, Timothy J and Miller, Christopher and Ding, Li and Raphael, Benjamin J and Mungall, Andrew J and Robertson, Gordon and Hoadley, Katherine and Triche Jr, Timothy J and Laird, Peter W and Baty, Jack D and Fulton, Lucinda L and Fulton, Robert and Heath, Sharon E and Kalicki-Veizer, Joelle and Kandoth, Cyriac and Klco, Jeffery M and Koboldt, Daniel C and Kanchi, Krishna-Latha and Kulkarni, Shashikant and Lamprecht, Tamara L and Larson, David E and Lin, G and Lu, Charles and McLellan, Michael D and McMichael, Joshua F and Payton, Jacqueline and Schmidt, Heather and Spencer, David H and Tomasson, Michael H and Wallis, John W and Wartman, Lukas D and Watson, Mark A and Welch, John and Wendl, Michael C and Ally, Adrian and Balasundaram, Miruna and Birol, Inanc and Butterfield, Yaron and Chiu, Readman and Chu, Andy and Chuah, Eric and Chun, Hye-Jung and Corbett, Richard and Dhalla, Noreen and Guin, Ranabir and He, An and Hirst, Carrie and Hirst, Martin and Holt, Robert A and Jones, Steven and Karsan, Aly and Lee, Darlene and Li, Haiyan I and Marra, Marco A and Mayo, Michael and Moore, Richard A and Mungall, Karen and Parker, Jeremy and Pleasance, Erin and Plettner, Patrick and Schein, Jacquie and Stoll, Dominik and Swanson, Lucas and Tam, Angela and Thiessen, Nina and Varhol, Richard and Wye, Natasja and Zhao, Yongjun and Gabriel, Stacey and Getz, Gad and Sougnez, Carrie and Zou, Lihua and Leiserson, Mark D. M and Vandin, Fabio and Wu, Hsin-Ta and Applebaum, Frederick and Baylin, Stephen B and Akbani, Rehan and Broom, Bradley M and Chen, Ken and Motter, Thomas C and Nguyen, Khanh and Weinstein, John N and Zhang, Nianziang and Ferguson, Martin L and Adams, Christopher and Black, Aaron and Bowen, Jay and Gastier-Foster, Julie and Grossman, Thomas and Lichtenberg, Tara and Wise, Lisa and Davidsen, Tanja and Demchok, John A and Mills Shaw, Kenna R and Sheth, Margi and Sofia, Heidi J and Yang, Liming and Downing, James R and Eley, Greg and ... and The Cancer Genome Atlas Research Network and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
The New England Journal of Medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 22, pp. 2059 - 2074
Journal Article
JAMA, ISSN 0098-7484, 08/2015, Volume 314, Issue 8, pp. 811 - 822
Journal Article
Nature Genetics, ISSN 1061-4036, 01/2017, Volume 49, Issue 2, pp. 170 - 174
CIViC is an expert-crowdsourced knowledgebase for Clinical Interpretation of Variants in Cancer describing the therapeutic, prognostic, diagnostic and... 
CATALOG | DATABASE | GENETICS | PERFORMANCE | GUIDELINES | GENETICS & HEREDITY | ONTOLOGY | MUTATIONS | Usage | Care and treatment | Genetic variation | Innovations | Knowledge-based systems | Identification and classification | Cancer | Medicine | Crowdsourcing | Medical research | Researchers | Ontology | Experts | Licenses | Genomes | Mutation | Cancer therapies | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2018, Volume 379, Issue 24, pp. 2330 - 2341
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2018, Volume 379, Issue 11, pp. 1028 - 1041
Journal Article